Indeed, the European Generic Medicines Association has concluded that, "the procedures are complicated, the terms under which new producers must operate are very restrictive and the various measures proposed are ambiguous."
Indeed, the European Generic Medicines Association has concluded that, "the procedures are complicated, the terms under which new producers must operate are very restrictive and the various measures proposed are ambiguous."